-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, HYiSKrnWRq6U4LOcjsaLiq5FttlZe2AYekwyPdvmdWkPMWJWueMjXlAgIeGGfT+z UvGfHBToIypnynefkQlkiA== 0001266375-07-000048.txt : 20070705 0001266375-07-000048.hdr.sgml : 20070704 20070705165441 ACCESSION NUMBER: 0001266375-07-000048 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20070702 FILED AS OF DATE: 20070705 DATE AS OF CHANGE: 20070705 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: PROGENICS PHARMACEUTICALS INC CENTRAL INDEX KEY: 0000835887 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 133379479 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 777 OLD SAW MILL RIVER ROAD CITY: TARRYTOWN STATE: NY ZIP: 10591 BUSINESS PHONE: 9147892800 MAIL ADDRESS: STREET 1: 777 OLD SAW MILL RIVER ROAD CITY: TARRYTOWN STATE: NY ZIP: 10591 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Baker Mark Robert CENTRAL INDEX KEY: 0001331438 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-23143 FILM NUMBER: 07965166 BUSINESS ADDRESS: BUSINESS PHONE: 718 852-5927 MAIL ADDRESS: STREET 1: 120 STATE STREET CITY: BROOKLYN STATE: NY ZIP: 11201 4 1 edgardoc.xml PRIMARY DOCUMENT X0202 4 2007-07-02 0 0000835887 PROGENICS PHARMACEUTICALS INC PGNX 0001331438 Baker Mark Robert 777 OLD SAW MILL RIVER ROAD TARRYTOWN NY 10591 0 1 0 0 General Counsel Common Stock 2007-07-02 4 A 0 13333 0 A 24398 D Common Stock 2007-07-02 4 M 0 3451 18.71 A 27900 D Common Stock 2007-07-02 4 F 0 3140 22.01 D 24760 D ESPP (right to buy) 18.71 2007-07-02 4 M 0 3451 0 D 2006-06-20 2007-07-03 Common Stock 3451 0 D ESPP (right to buy) 21.57 2007-07-02 4 A 0 652 0 A 2008-01-02 2008-01-02 Common Stock 652 652 D Non-Qualified Stock Option (right to buy) 22.01 2007-07-02 4 A 0 10000 0 A 2008-07-02 2017-07-02 Common Stock 10000 10000 D Restricted Stock shall be released in four equal installments, commencing one year from the transaction date. Acquired upon the complete exercise of a grant under the Non-Qualified Employee Stock Purchase Plan, which grant was previously reported at the start of a six month option term, to acquire common stock up to an option amount which is 25% of the optionee's quarterly salary less $6,250, at a purchase price equal to the lower of 100% of the market value on the date of grant or 85% of the market value on the date of exercise. Includes shares of common stock acquired from the non-reportable exercise under a Qualified Employee Stock Purchase Plan. The option was granted on the first day of the option term and previously reported as a right to purchase shares of the Company's common stock at an exercise price equal to the market value on the date of grant. In accordance with the Non-Qualified Employee Stock Purchase Plan, the option is ultimately exercisable for an exercise price which is the lower of 100% of the market value on the grant date or 85% of the market value on the day prior to the exercise date. The number of shares exercised is based on the option amount divided by the lower of 100% of the market value on the grant date or 85% of the market value on the day prior to the exercise date. Granted under the Company's Non-Qualified Employeee Stock Purchase Plan. The option will be exercisable for that number of shares equal to the option amount (25% of the optionee's quarterly salary less $6,250) divided by the lesser of the market value of the common stock on the grant date or 85% of the market value on the day prior to the exercise date. The stock options become exercisable in four equal installments, commencing one year from the grant date. Mark R. Baker 2007-07-05 -----END PRIVACY-ENHANCED MESSAGE-----